Protein kinase C α is involved in the regulation of AXL receptor tyrosine kinase expression in triple-negative breast cancer cells

Chia Herng Yue, Liang Chih Liu, Erl Shyh Kao, Ho Lin, Li Sung Hsu, Chih Wei Hsu, Yu Yu Lin, Yi Syuan Lin, Jer Yuh Liu, Chia Jen Lee

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

AXL receptor tyrosine kinase is overexpressed in triple-negative breast cancer (TNBC), and has a function in cancer progression and metastases. However, the mechanism underlying AXL gene regulation in TNBC remains unknown. In this study, the involvement of protein kinase C α (PKCα) in the expression of AXL was investigated in human TNBC cells. The microarray data from other studies showed that PKCα is significantly correlated with AXL expression in TNBC cell lines. Tissue array analysis also confirmed their correlation in TNBC. The PKCα inhibitor Go6976 was used to treat MDA-MB-231 and Hs578T TNBC cells, which resulted in decreased expression of AXL and epithelia-mesenchymal transition-related gene vimentin, and decreased cell proliferation. An MZF-1 acidic domain fragment (MZF-1 peptide), which was designed to downregulate PKCα expression, was transfected into the cells and resulted in inhibition of AXL expression. This effect was reversed by co-treatment with the constitutive form of PKCα. Moreover, the downregulation of PKCα was also confirmed by treatment with TAT-fused MZF-1 peptide. Thus, the current study proposes that AXL may be correlated with PKCα-dependent TNBC cells, and could be modulated by MZF-1 peptides.

Original languageEnglish (US)
Pages (from-to)1636-1642
Number of pages7
JournalMolecular Medicine Reports
Volume14
Issue number2
DOIs
StatePublished - Aug 1 2016

Fingerprint

Triple Negative Breast Neoplasms
Receptor Protein-Tyrosine Kinases
Protein Kinase C
Cells
Peptides
Down-Regulation
Tissue Array Analysis
Protein C Inhibitor
Cell proliferation
Vimentin
Protein Kinase Inhibitors
Microarrays
Gene expression
Genes
Epithelium
Cell Proliferation
Tissue
Neoplasm Metastasis
Cell Line

Keywords

  • AXL receptor tyrosine kinase
  • Kinase protein kinase C α
  • Triple-negative breast cancer

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Oncology
  • Genetics
  • Cancer Research

Cite this

Protein kinase C α is involved in the regulation of AXL receptor tyrosine kinase expression in triple-negative breast cancer cells. / Yue, Chia Herng; Liu, Liang Chih; Kao, Erl Shyh; Lin, Ho; Hsu, Li Sung; Hsu, Chih Wei; Lin, Yu Yu; Lin, Yi Syuan; Liu, Jer Yuh; Lee, Chia Jen.

In: Molecular Medicine Reports, Vol. 14, No. 2, 01.08.2016, p. 1636-1642.

Research output: Contribution to journalArticle

Yue, CH, Liu, LC, Kao, ES, Lin, H, Hsu, LS, Hsu, CW, Lin, YY, Lin, YS, Liu, JY & Lee, CJ 2016, 'Protein kinase C α is involved in the regulation of AXL receptor tyrosine kinase expression in triple-negative breast cancer cells', Molecular Medicine Reports, vol. 14, no. 2, pp. 1636-1642. https://doi.org/10.3892/mmr.2016.5424
Yue, Chia Herng ; Liu, Liang Chih ; Kao, Erl Shyh ; Lin, Ho ; Hsu, Li Sung ; Hsu, Chih Wei ; Lin, Yu Yu ; Lin, Yi Syuan ; Liu, Jer Yuh ; Lee, Chia Jen. / Protein kinase C α is involved in the regulation of AXL receptor tyrosine kinase expression in triple-negative breast cancer cells. In: Molecular Medicine Reports. 2016 ; Vol. 14, No. 2. pp. 1636-1642.
@article{e62fbebe90ca480da0a5857dc6e29023,
title = "Protein kinase C α is involved in the regulation of AXL receptor tyrosine kinase expression in triple-negative breast cancer cells",
abstract = "AXL receptor tyrosine kinase is overexpressed in triple-negative breast cancer (TNBC), and has a function in cancer progression and metastases. However, the mechanism underlying AXL gene regulation in TNBC remains unknown. In this study, the involvement of protein kinase C α (PKCα) in the expression of AXL was investigated in human TNBC cells. The microarray data from other studies showed that PKCα is significantly correlated with AXL expression in TNBC cell lines. Tissue array analysis also confirmed their correlation in TNBC. The PKCα inhibitor Go6976 was used to treat MDA-MB-231 and Hs578T TNBC cells, which resulted in decreased expression of AXL and epithelia-mesenchymal transition-related gene vimentin, and decreased cell proliferation. An MZF-1 acidic domain fragment (MZF-1 peptide), which was designed to downregulate PKCα expression, was transfected into the cells and resulted in inhibition of AXL expression. This effect was reversed by co-treatment with the constitutive form of PKCα. Moreover, the downregulation of PKCα was also confirmed by treatment with TAT-fused MZF-1 peptide. Thus, the current study proposes that AXL may be correlated with PKCα-dependent TNBC cells, and could be modulated by MZF-1 peptides.",
keywords = "AXL receptor tyrosine kinase, Kinase protein kinase C α, Triple-negative breast cancer",
author = "Yue, {Chia Herng} and Liu, {Liang Chih} and Kao, {Erl Shyh} and Ho Lin and Hsu, {Li Sung} and Hsu, {Chih Wei} and Lin, {Yu Yu} and Lin, {Yi Syuan} and Liu, {Jer Yuh} and Lee, {Chia Jen}",
year = "2016",
month = "8",
day = "1",
doi = "10.3892/mmr.2016.5424",
language = "English (US)",
volume = "14",
pages = "1636--1642",
journal = "Molecular Medicine Reports",
issn = "1791-2997",
publisher = "Spandidos Publications",
number = "2",

}

TY - JOUR

T1 - Protein kinase C α is involved in the regulation of AXL receptor tyrosine kinase expression in triple-negative breast cancer cells

AU - Yue, Chia Herng

AU - Liu, Liang Chih

AU - Kao, Erl Shyh

AU - Lin, Ho

AU - Hsu, Li Sung

AU - Hsu, Chih Wei

AU - Lin, Yu Yu

AU - Lin, Yi Syuan

AU - Liu, Jer Yuh

AU - Lee, Chia Jen

PY - 2016/8/1

Y1 - 2016/8/1

N2 - AXL receptor tyrosine kinase is overexpressed in triple-negative breast cancer (TNBC), and has a function in cancer progression and metastases. However, the mechanism underlying AXL gene regulation in TNBC remains unknown. In this study, the involvement of protein kinase C α (PKCα) in the expression of AXL was investigated in human TNBC cells. The microarray data from other studies showed that PKCα is significantly correlated with AXL expression in TNBC cell lines. Tissue array analysis also confirmed their correlation in TNBC. The PKCα inhibitor Go6976 was used to treat MDA-MB-231 and Hs578T TNBC cells, which resulted in decreased expression of AXL and epithelia-mesenchymal transition-related gene vimentin, and decreased cell proliferation. An MZF-1 acidic domain fragment (MZF-1 peptide), which was designed to downregulate PKCα expression, was transfected into the cells and resulted in inhibition of AXL expression. This effect was reversed by co-treatment with the constitutive form of PKCα. Moreover, the downregulation of PKCα was also confirmed by treatment with TAT-fused MZF-1 peptide. Thus, the current study proposes that AXL may be correlated with PKCα-dependent TNBC cells, and could be modulated by MZF-1 peptides.

AB - AXL receptor tyrosine kinase is overexpressed in triple-negative breast cancer (TNBC), and has a function in cancer progression and metastases. However, the mechanism underlying AXL gene regulation in TNBC remains unknown. In this study, the involvement of protein kinase C α (PKCα) in the expression of AXL was investigated in human TNBC cells. The microarray data from other studies showed that PKCα is significantly correlated with AXL expression in TNBC cell lines. Tissue array analysis also confirmed their correlation in TNBC. The PKCα inhibitor Go6976 was used to treat MDA-MB-231 and Hs578T TNBC cells, which resulted in decreased expression of AXL and epithelia-mesenchymal transition-related gene vimentin, and decreased cell proliferation. An MZF-1 acidic domain fragment (MZF-1 peptide), which was designed to downregulate PKCα expression, was transfected into the cells and resulted in inhibition of AXL expression. This effect was reversed by co-treatment with the constitutive form of PKCα. Moreover, the downregulation of PKCα was also confirmed by treatment with TAT-fused MZF-1 peptide. Thus, the current study proposes that AXL may be correlated with PKCα-dependent TNBC cells, and could be modulated by MZF-1 peptides.

KW - AXL receptor tyrosine kinase

KW - Kinase protein kinase C α

KW - Triple-negative breast cancer

UR - http://www.scopus.com/inward/record.url?scp=84978417769&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978417769&partnerID=8YFLogxK

U2 - 10.3892/mmr.2016.5424

DO - 10.3892/mmr.2016.5424

M3 - Article

VL - 14

SP - 1636

EP - 1642

JO - Molecular Medicine Reports

JF - Molecular Medicine Reports

SN - 1791-2997

IS - 2

ER -